Barclays raised the firm’s price target on Chemours to $32 from $28 and keeps an Equal Weight rating on the shares. The analyst says belief in peaking rates and six quarters of destocking have led to some renewed optimism in materials shares. The firm ask if this is the start of a new cycle or another head-fake like last year’s “China reopening”? It is unclear, says Barclays, which is staying cautious with barbelled positioning in chemicals and packaging.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on CC:
- Chemours, DuPont, Corteva affirm support for PFAS settlement
- Chemours works with Chinese authorities to shut down counterfeit Viton FreeFlow
- Chemours price target raised by $2 at Morgan Stanley, here’s why
- Elastic upgraded, Alibaba downgraded: Wall Street’s top analyst calls
- Chemours upgraded to Outperform from Sector Perform at RBC Capital